Filtered By:
Source: European Respiratory Journal
Therapy: Chemotherapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Hippo Effector YAP regulates Autophagy key effector p62 in Lung Adenocarcinoma
Conclusion: Taken together, our findings uncover a significant regulatory axis for autophagic key factor p62 by Hippo effector YAP in EGFR-TKI resistant lung adenocarcinoma. Targeting the autophagy by YAP could provide an effective therapeutic strategy for intractable lung cancer such as EGFR-TKI-resistant lung adenocarcinoma.
Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Chung, C., Kim, J. O., Park, D. I., Lee, D., Lee, J. E., Park, H. S., Kang, D. H., Kim, Y. Tags: Lung cancer Source Type: research
